Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Drugs Outcomes Research and Policies

This article is part of the Research TopicPharmacist and patient safety: Focus on drug safetyView all 20 articles

The Effect of Scheduled Metamizole on Opioid Consumption after Cardiac Surgery

Provisionally accepted
  • 1Ariel University Dr Miriam and Sheldon G Adelson School of Medicine, Ari'el, Israel
  • 2Reichman University, Herzliya, Israel
  • 3Rabin Medical Center, Petah Tikva, Israel

The final, formatted version of the article will be published soon.

This retrospective study evaluates the impact of implementing a standardized scheduled metamizole dosing protocol within a multimodal analgesia approach after cardiac surgery. The results showed that scheduled metamizole administration was associated with lower opioid consumption, while maintaining adequate pain control and safety. Pain scores measured by the Numeric Rating Scale improved from 1.12 pre-protocol to 0.89 post-protocol (p < 0.0001). Mean opioid consumption decreased from 119.51 mg morphine equivalents to 95.91 mg (p < 0.0001). No cases of clinically relevant agranulocytosis or persistent neutropenia were observed. Renal function, assessed by changes in serum creatinine, showed no significant differences between groups, suggesting renal safety. Despite improved analgesia and reduced opioid use, hospital length of stay increased slightly, potentially due to confounding factors. Our findings support scheduled metamizole as a safe and effective opioid-sparing agent in postoperative cardiac surgery pain management. Further prospective randomized trials are warranted to confirm these results and establish optimal protocols.

Keywords: cardiac surgeries, Metamizol, Multimodal analgesia, opiod analgesics, Pain Management, post operation care

Received: 14 Dec 2025; Accepted: 14 Jan 2026.

Copyright: © 2026 Slevin-Kish, Seidenberg, Grunberger, Mishali, Hefets, Singer and sitton. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Michal Slevin-Kish
Chen Seidenberg
Adina Grunberger

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.